识别和治疗尤文肉瘤患者。

Recognizing and treating patients with Ewing sarcoma.

机构信息

At the time this article was written, Ashley Windheuser was a student in the PA program at Albany (N.Y.) Medical College. She now practices at New York-Presbyterian/Weill Cornell Medical Center in New York City. Nathan Gardner is the program director and an assistant professor in the PA program at Albany Medical College. The authors have disclosed no potential conflicts of interest, financial or otherwise.

出版信息

JAAPA. 2023 Sep 1;36(9):1-4. doi: 10.1097/01.JAA.0000937324.58262.55.

DOI:10.1097/01.JAA.0000937324.58262.55

PMID:37668491

Abstract

This article reviews the cause, presentation, diagnosis, and management of Ewing sarcoma, the second most common primary bone malignancy in children and young adults. Recent research has provided advances in understanding the cause of Ewing sarcoma as well as improved treatment regimens. However, much is still unknown and additional research is needed to continue to improve the overall prognosis, which ranges from 70% to 80% 5-year survival for patients with localized disease. Improving clinician knowledge about Ewing sarcoma will help shorten time to diagnosis and improve survival rates.

摘要

这篇文章回顾了尤因肉瘤的病因、表现、诊断和治疗，它是儿童和青年中第二常见的原发性骨恶性肿瘤。最近的研究为理解尤因肉瘤的病因提供了进展，并改进了治疗方案。然而，仍有许多未知之处，需要进一步研究以继续提高整体预后，局部疾病患者的 5 年生存率范围为 70%至 80%。提高临床医生对尤因肉瘤的认识将有助于缩短诊断时间并提高生存率。